You are here: All Products  > Yingli Reports Positive Data from Phase III Trial of Linperlisib for T-cell Lymphoma

Yingli Reports Positive Data from Phase III Trial of Linperlisib for T-cell Lymphoma

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products